Biologics

Spinal Implants

Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

BELGRADE, Mont. , July 28, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended